hydrochlorothiazide has been researched along with Dyslipidemia in 7 studies
Hydrochlorothiazide: A thiazide diuretic often considered the prototypical member of this class. It reduces the reabsorption of electrolytes from the renal tubules. This results in increased excretion of water and electrolytes, including sodium, potassium, chloride, and magnesium. It is used in the treatment of several disorders including edema, hypertension, diabetes insipidus, and hypoparathyroidism.
hydrochlorothiazide : A benzothiadiazine that is 3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide substituted by a chloro group at position 6 and a sulfonamide at 7. It is diuretic used for the treatment of hypertension and congestive heart failure.
| Excerpt | Relevance | Reference |
|---|---|---|
| " An additional aim is to assess the effect of the polypill on LDL-c and BP compared to the administration of separate pills of identically dosed components of the polypill." | 2.79 | The evening versus morning polypill utilization study: the TEMPUS rationale and design. ( Bots, ML; Grobbee, DE; Lafeber, M; Rodgers, A; Spiering, W; Thom, S; Visseren, FL; Webster, R, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 6 (85.71) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pais, P | 1 |
| Jung, H | 1 |
| Dans, A | 1 |
| Zhu, J | 1 |
| Liu, L | 1 |
| Kamath, D | 1 |
| Bosch, J | 1 |
| Lonn, E | 1 |
| Yusuf, S | 1 |
| Ridker, PM | 1 |
| Ferket, BS | 1 |
| Hunink, MG | 1 |
| Khanji, M | 1 |
| Agarwal, I | 1 |
| Fleischmann, KE | 1 |
| Petersen, SE | 1 |
| Andalib, A | 1 |
| Akhtari, S | 1 |
| Rigal, R | 1 |
| Curnew, G | 1 |
| Leclerc, JM | 1 |
| Vaillancourt, M | 1 |
| Tardif, JC | 1 |
| Cicero, AF | 1 |
| De Sando, V | 1 |
| Izzo, R | 1 |
| Vasta, A | 1 |
| Trimarco, A | 1 |
| Borghi, C | 1 |
| Lafeber, M | 1 |
| Grobbee, DE | 1 |
| Bots, ML | 1 |
| Thom, S | 1 |
| Webster, R | 1 |
| Rodgers, A | 1 |
| Visseren, FL | 1 |
| Spiering, W | 1 |
| Fitzgerald, MA | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomised Controlled Cross-over Trial to Evaluate Evening Versus Morning Administration of a Cardiovascular Polypill[NCT01506505] | 78 participants (Actual) | Interventional | 2012-07-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 trials available for hydrochlorothiazide and Dyslipidemia
| Article | Year |
|---|---|
Impact of blood pressure lowering, cholesterol lowering and their combination in Asians and non-Asians in those without cardiovascular disease: an analysis of the HOPE 3 study.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Asia; Asian People; Benzimid | 2019 |
Effect of a combined nutraceutical containing Orthosiphon stamineus effect on blood pressure and metabolic syndrome components in hypertensive dyslipidaemic patients: a randomized clinical trial.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calc | 2012 |
The evening versus morning polypill utilization study: the TEMPUS rationale and design.
Topics: Administration, Oral; Antihypertensive Agents; Aspirin; Biomarkers; Blood Platelets; Blood Pressure; | 2014 |
4 other studies available for hydrochlorothiazide and Dyslipidemia
| Article | Year |
|---|---|
Is Statin Monotherapy the Perfect Polypill?
Topics: Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Cardiovascular Diseases; Clinical Trial | 2016 |
Cost-effectiveness of the polypill versus risk assessment for prevention of cardiovascular disease.
Topics: Administration, Oral; Adult; Aged; Amlodipine; Antihypertensive Agents; Cardiovascular Diseases; Com | 2017 |
Determinants of masked hypertension in hypertensive patients treated in a primary care setting.
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents | 2012 |
Hyponatremia associated with SSRI use in a 65-year-old woman.
Topics: Depressive Disorder; Diuretics; Drug Monitoring; Drug Synergism; Dyslipidemias; Female; Humans; Hydr | 2008 |